• Abstract
• Full-Text PDF [127 KB]
• Full-Text XML
• Article Versions Notes
• Correction

• Article Statistics
• PubMed/Medline
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Wiart, C
• [+] on Google Scholar
• Wiart, C
• [+] on PubMed
• Wiart, C

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Molecules 2013, 18(3), 2587-2588; doi:10.3390/molecules18032587

Comment

Lee et al., Inhibitory Effect and Mechanism of Antiproliferation of Isoatriplicolide Tiglate (PCAC) from Paulownia Coreana. Molecules 2012, 17, 5945-5951: A Note Regarding Paulownia coreana.

Christophe Wiart

School of Biomedical Sciences, University of Nottingham, Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK

Received: 18 February 2013; in revised form: 22 February 2013 / Accepted: 22 February 2013 / Published: 26 February 2013

(This article belongs to the Section Natural Products)

Download PDF Full-Text [127 KB, uploaded 26 February 2013 08:59 CET]

Abstract: I read with interest the article by Lee et al. entitled “Inhibitory Effect and Mechanism of Antiproliferation of Isoatriplicolide Tiglate (PCAC) from Paulownia Coreana” [1]. This article is quite interesting and the authors should be complimented for the significant amount of work they have done. The purpose of this letter is to call attention to the need for some clarification on the name of the plant described in this article. Lee et al. state: “Paulownia coreana has traditionally been used as the medicine and health food in the treatment of cancer and infectious diseases.” and elsewhere: “In fact, many cancer research studies have been conducted using traditional medicinal plants such as P. coreana.” [1].

Correction

• Correction

  A correction was published on 7 March 2013: http://www.mdpi.com/1420-3049/18/3/3041 (PDF, 117 KB)

Article Statistics

Cite This Article